NIAID Centralized Sequencing Protocol | MicrobiomeTrials← Back to trialsNCT03206099
NIAID Centralized Sequencing Protocol
RecruitingOBSERVATIONAL
Trial Details
Start: 2017-07-31Est. Completion: 2029-12-31
Enrollment target: 20,000 participants Locations- Children's National Health System, Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Pityriasis Rubra Pilaris
The purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubr…
Scottsdale, United StatesCompleted Sep 2, 2025
Atopic Dermatitis
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<1…
Birmingham, United StatesEst. completion Jul 13, 2026